From: | Becker's GI & Endoscopy <editorial@beckershealthcare.com> |
Subject: | Post-'superbug' outbreak: 6 FDA recommendations for ERCP scope reprocessing | Valeant to acquire Salix for $14.5B | Healthcare's 5-year forecast: Stagnation with a chance of decline |
Reply: | editorial@beckershealthcare.com |
|
|